Medical Devices & Surgical Technology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices & Surgical Technology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Thyroid Cancer
Galectin-3 immunoassay facilitates diagnosis of occult papillary thyroid carcinoma
July 25th, 2004
A galectin-3 immunoassay facilitates diagnosis of occult papillary thyroid carcinoma. According to a study from Italy, "[g]alectin-3 has been found recently to be neo-expressed in thyroid cancers compared to benign lesions and it could therefore be considered a marker of malignancy." T. Pisani and coauthors at the S. Andrea University Hospital in Rome described "the case of a 36-year-old woman with a history of occasional dysphagia and dysphonia first observed in November 2000." "Thyroid ultrasound scan revealed two subcentimetric nodules in the tight lobe," published data showed. "The larger one underwent ultrasound-guided...
Source: Medical Devices & Surgical Technology Week (2004-07-25)
|
